Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis

Biological disease-modifying anti-rheumatic drugs (bDMARDs) are widely used for the treatment of chronic inflammatory rheumatic diseases. Since the introduction of tumor necrosis factor alpha (TNF-) inhibitors, the treatment of rheumatoid arthritis has been revolutionized. The approach of targeting...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria N. Chamurlieva, Yulia L. Korsakova, Stefka G. Radenska-Lopovok, Tatiana V. Korotaeva
Formato: article
Lenguaje:RU
Publicado: State Scientific Center of Dermatovenereology and Cosmetology 2021
Materias:
Acceso en línea:https://doaj.org/article/91175d6222fa48c88b9edfe7b48b771d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!